Bell Michael Brian, an insider at Guardant Health Inc (GH), sold 28,052 shares of the company on December 4, 2025. The shares were sold at a price of $107.26 each, resulting in a total transaction value of $3.01 million. Following this sale, Brian retains 28,052 shares of the company.
Guardant Health, based in Palo Alto, California, is a precision oncology company focused on cancer treatment through proprietary blood-based tests and advanced analytics. The company went public on October 4, 2018, and currently has a market capitalization of $12.1 billion. Its tests, including the Guardant360 and Guardant Reveal, are designed to improve patient outcomes across various stages of cancer care.
Insider transactions provide transparency into how executives view their stock. However, selling activity by a single insider should be considered in context, as it may stem from personal financial needs or regulatory reasons. Investors are encouraged to examine broader insider activity over time rather than isolated transactions.
Guardant Health is set to report its upcoming earnings on April 28, 2026, with an estimated EPS of -$0.66 and revenue expectations of $279.1 million.